The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
85263095 8526309 5 F 20120221 20160815 20120423 20160818 EXP JP-GLAXOSMITHKLINE-B0795407A GLAXOSMITHKLINE 30.79 YR M Y 0.00000 20160818 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
85263095 8526309 1 PS LAMOTRIGINE. LAMOTRIGINE 1 Oral 25 MG, QD 20241 25 MG TABLET QD
85263095 8526309 2 SS VALPROATE SODIUM. VALPROATE SODIUM 1 Oral UNK U 0
85263095 8526309 3 C Amoxan AMOXAPINE 1 Oral 25 MG, QID 0 25 MG QID
85263095 8526309 4 C LUVOX FLUVOXAMINE MALEATE 1 0
85263095 8526309 5 C DESYREL TRAZODONE HYDROCHLORIDE 1 0
85263095 8526309 6 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 UNK 0
85263095 8526309 7 C TEGRETOL CARBAMAZEPINE 1 300 MG, 1D 0 300 MG QD
85263095 8526309 8 C ANAFRANIL CLOMIPRAMINE HYDROCHLORIDE 1 25 MG, QID 0 25 MG QID
85263095 8526309 9 C LEXAPRO ESCITALOPRAM OXALATE 1 Oral 20 MG, QD 0 20 MG QD
85263095 8526309 10 C Valerin VALPROATE SODIUM 1 100 MG, TID 0 100 MG TID
85263095 8526309 11 C ROZEREM RAMELTEON 1 8 MG, QD U 0 8 MG QD
85263095 8526309 12 C Tetramide MIANSERIN 1 30 MG, QD 0 30 MG QD
85263095 8526309 13 C Buscopan BUTYLSCOPOLAMINE BROMIDE 1 0 2 DF QD
85263095 8526309 14 C CALONAL ACETAMINOPHEN 1 0 1 DF QD
85263095 8526309 15 C REBAMIPIDE REBAMIPIDE 1 1 DF, TID 0 1 DF TID
85263095 8526309 16 C Lac-B BIFIDOBACTERIUM SPP. 1 1 G, TID 0 1 G TID
85263095 8526309 17 C VOLTAREN DICLOFENAC SODIUM 1 0 1 DF QD

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
85263095 8526309 DE
85263095 8526309 HO
85263095 8526309 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
85263095 8526309 Abdominal pain upper
85263095 8526309 Alanine aminotransferase increased
85263095 8526309 Aspartate aminotransferase increased
85263095 8526309 Blood alkaline phosphatase increased
85263095 8526309 Blood creatine increased
85263095 8526309 Blood creatine phosphokinase increased
85263095 8526309 Blood lactate dehydrogenase increased
85263095 8526309 Blood urea increased
85263095 8526309 C-reactive protein increased
85263095 8526309 Chills
85263095 8526309 Conjunctival hyperaemia
85263095 8526309 Diarrhoea
85263095 8526309 Gamma-glutamyltransferase increased
85263095 8526309 Generalised erythema
85263095 8526309 Haematuria
85263095 8526309 Lip erosion
85263095 8526309 Multiple organ dysfunction syndrome
85263095 8526309 Pyrexia
85263095 8526309 Rash
85263095 8526309 Rash maculo-papular
85263095 8526309 Somnolence
85263095 8526309 Toxic epidermal necrolysis
85263095 8526309 Vomiting
85263095 8526309 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
85263095 8526309 1 20120218 20120302 0
85263095 8526309 6 20101109 0
85263095 8526309 7 20110830 20110921 0
85263095 8526309 8 20110906 0
85263095 8526309 9 20111226 20120302 0
85263095 8526309 10 20110925 0
85263095 8526309 12 20120218 20120221 0